Aurelie Ayme
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study.
Journal: Swiss medical weekly
Published: April 03, 2023
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature.
Journal: Familial cancer
Published: October 22, 2021
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Journal: Scientific reports
Published: November 03, 2020
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Journal: Scientific reports
Published: February 22, 2019
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients.
Journal: Breast cancer research and treatment
Published: August 15, 2018
Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2017
Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.
Journal: Cancer medicine
Published: September 06, 2016
Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.
Journal: Breast cancer research and treatment
Published: October 12, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026